292 related articles for article (PubMed ID: 27827301)
21. Oxidized DNA Precursors Cleanup by NUDT1 Contributes to Vascular Remodeling in Pulmonary Arterial Hypertension.
Vitry G; Paulin R; Grobs Y; Lampron MC; Shimauchi T; Lemay SE; Tremblay E; Habbout K; Awada C; Bourgeois A; Nadeau V; Paradis R; Breuils-Bonnet S; Roux-Dalvai F; Orcholski M; Potus F; Provencher S; Boucherat O; Bonnet S
Am J Respir Crit Care Med; 2021 Mar; 203(5):614-627. PubMed ID: 33021405
[No Abstract] [Full Text] [Related]
22. Potent and Selective Inhibitors of MTH1 Probe Its Role in Cancer Cell Survival.
Kettle JG; Alwan H; Bista M; Breed J; Davies NL; Eckersley K; Fillery S; Foote KM; Goodwin L; Jones DR; Käck H; Lau A; Nissink JW; Read J; Scott JS; Taylor B; Walker G; Wissler L; Wylot M
J Med Chem; 2016 Mar; 59(6):2346-61. PubMed ID: 26878898
[TBL] [Abstract][Full Text] [Related]
23. Visualization of oxidized guanine nucleotides accumulation in living cells with split MutT.
Fujikawa Y; Kawai H; Suzuki T; Kamiya H
Nucleic Acids Res; 2024 Jun; 52(11):6532-6542. PubMed ID: 38738661
[TBL] [Abstract][Full Text] [Related]
24. Enhancing Repair of Oxidative DNA Damage with Small-Molecule Activators of MTH1.
Lee Y; Onishi Y; McPherson L; Kietrys AM; Hebenbrock M; Jun YW; Das I; Adimoolam S; Ji D; Mohsen MG; Ford JM; Kool ET
ACS Chem Biol; 2022 Aug; 17(8):2074-2087. PubMed ID: 35830623
[TBL] [Abstract][Full Text] [Related]
25. Differential anti-tumour effects of MTH1 inhibitors in patient-derived 3D colorectal cancer cultures.
van der Waals LM; Laoukili J; Jongen JMJ; Raats DA; Borel Rinkes IHM; Kranenburg O
Sci Rep; 2019 Jan; 9(1):819. PubMed ID: 30692572
[TBL] [Abstract][Full Text] [Related]
26. AuNP flares-capped mesoporous silica nanoplatform for MTH1 detection and inhibition.
Gao W; Cao W; Sun Y; Wei X; Xu K; Zhang H; Tang B
Biomaterials; 2015 Nov; 69():212-21. PubMed ID: 26298289
[TBL] [Abstract][Full Text] [Related]
27. Augment of Oxidative Damage with Enhanced Photodynamic Process and MTH1 Inhibition for Tumor Therapy.
Hu JJ; Chen Y; Li ZH; Peng SY; Sun Y; Zhang XZ
Nano Lett; 2019 Aug; 19(8):5568-5576. PubMed ID: 31262183
[TBL] [Abstract][Full Text] [Related]
28. MTH1 inhibitor amplifies the lethality of reactive oxygen species to tumor in photodynamic therapy.
Zhao L; Li J; Su Y; Yang L; Chen L; Qiang L; Wang Y; Xiang H; Tham HP; Peng J; Zhao Y
Sci Adv; 2020 Mar; 6(10):eaaz0575. PubMed ID: 32181355
[TBL] [Abstract][Full Text] [Related]
29. Identification and structure-activity relationship of purine derivatives as novel MTH1 inhibitors.
Kumar A; Kawamura T; Kawatani M; Osada H; Zhang KYJ
Chem Biol Drug Des; 2017 Jun; 89(6):862-869. PubMed ID: 27863017
[TBL] [Abstract][Full Text] [Related]
30. Karonudib is a promising anticancer therapy in hepatocellular carcinoma.
Hua X; Sanjiv K; Gad H; Pham T; Gokturk C; Rasti A; Zhao Z; He K; Feng M; Zang Y; Zhang J; Xia Q; Helleday T; Warpman Berglund U
Ther Adv Med Oncol; 2019; 11():1758835919866960. PubMed ID: 31489034
[TBL] [Abstract][Full Text] [Related]
31. MTH1 inhibition synergizes with ROS-inducing agents to trigger cervical cancer cells undergoing parthanatos.
Li C; Xue Y; Wu J; Zhang L; Yang T; Ai M; Han J; Zheng X; Wang R; Boldogh I; Ba X
Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167190. PubMed ID: 38657912
[TBL] [Abstract][Full Text] [Related]
32. Crystal Structures and Inhibitor Interactions of Mouse and Dog MTH1 Reveal Species-Specific Differences in Affinity.
Narwal M; Jemth AS; Gustafsson R; Almlöf I; Warpman Berglund U; Helleday T; Stenmark P
Biochemistry; 2018 Feb; 57(5):593-603. PubMed ID: 29281266
[TBL] [Abstract][Full Text] [Related]
33. Discovery of a new class of MTH1 inhibitor by X-ray crystallographic screening.
Yokoyama T; Kitakami R; Mizuguchi M
Eur J Med Chem; 2019 Apr; 167():153-160. PubMed ID: 30771603
[TBL] [Abstract][Full Text] [Related]
34. The Existence of MTH1-independent 8-oxodGTPase Activity in Cancer Cells as a Compensatory Mechanism against On-target Effects of MTH1 Inhibitors.
Samaranayake GJ; Troccoli CI; Zhang L; Huynh M; Jayaraj CJ; Ji D; McPherson L; Onishi Y; Nguyen DM; Robbins DJ; Karbaschi M; Cooke MS; Barrientos A; Kool ET; Rai P
Mol Cancer Ther; 2020 Feb; 19(2):432-446. PubMed ID: 31744893
[TBL] [Abstract][Full Text] [Related]
35. Increased MTH1-specific 8-oxodGTPase activity is a hallmark of cancer in colon, lung and pancreatic tissue.
McPherson LA; Troccoli CI; Ji D; Bowles AE; Gardiner ML; Mohsen MG; Nagathihalli NS; Nguyen DM; Robbins DJ; Merchant NB; Kool ET; Rai P; Ford JM
DNA Repair (Amst); 2019 Nov; 83():102644. PubMed ID: 31311767
[TBL] [Abstract][Full Text] [Related]
36. Suppression of mutagenesis by 8-hydroxy-2'-deoxyguanosine 5'-triphosphate (7,8-dihydro-8-oxo-2'-deoxyguanosine 5'-triphosphate) by human MTH1, MTH2, and NUDT5.
Hori M; Satou K; Harashima H; Kamiya H
Free Radic Biol Med; 2010 May; 48(9):1197-201. PubMed ID: 20144704
[TBL] [Abstract][Full Text] [Related]
37. Radiolabeled 6-(2, 3-Dichlorophenyl)-N4-methylpyrimidine-2, 4-diamine (TH287): A Potential Radiotracer for Measuring and Imaging MTH1.
Chen H; Afrin S; Guo Y; Chu W; Benzinger TLS; Rogers BE; Garbow JR; Perlmutter JS; Zhou D; Xu J
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33238630
[TBL] [Abstract][Full Text] [Related]
38. Cancer therapy. Targeting the poison within.
Smits VA; Gillespie DA
Cell Cycle; 2014; 13(15):2330-3. PubMed ID: 25483183
[TBL] [Abstract][Full Text] [Related]
39. MTH1 favors mesothelioma progression and mediates paracrine rescue of bystander endothelium from oxidative damage.
Magkouta SF; Pappas AG; Vaitsi PC; Agioutantis PC; Pateras IS; Moschos CA; Iliopoulou MP; Kosti CN; Loutrari HV; Gorgoulis VG; Kalomenidis IT
JCI Insight; 2020 Jun; 5(12):. PubMed ID: 32554927
[TBL] [Abstract][Full Text] [Related]
40. The MTH1 inhibitor TH588 demonstrates anti-tumoral effects alone and in combination with everolimus, 5-FU and gamma-irradiation in neuroendocrine tumor cells.
Aristizabal Prada ET; Orth M; Nölting S; Spöttl G; Maurer J; Auernhammer C
PLoS One; 2017; 12(5):e0178375. PubMed ID: 28542590
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
